Health Care & Life Sciences » Pharmaceuticals | Nantong Jinghua Pharmaceutical Co. Ltd.

Nantong Jinghua Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
726
574
774
872
1,102
1,334
Cost of Goods Sold (COGS) incl. D&A
529
365
493
459
581
732
Gross Income
197
209
282
413
521
602
SG&A Expense
149
159
195
221
262
308
EBIT
47
43
76
187
255
292
Unusual Expense
-
3
4
4
91
17
Non Operating Income/Expense
31
7
3
3
53
13
Interest Expense
3
9
4
6
5
10
Pretax Income
43
51
92
195
216
283
Income Tax
2
10
15
29
26
28
Equity in Affiliates
-
-
4
7
1
5
Consolidated Net Income
41
41
82
173
190
260
Net Income
36
39
78
165
175
230
Net Income After Extraordinaries
36
39
78
165
175
230
Net Income Available to Common
36
39
78
165
175
230
EPS (Basic)
0.06
0.07
0.10
0.20
0.21
0.28
Basic Shares Outstanding
600
600
785
841
841
833
EPS (Diluted)
0.06
0.07
0.10
0.20
0.21
0.28
Diluted Shares Outstanding
600
600
785
841
841
833
EBITDA
72
83
122
247
319
371
Other Operating Expense
1
7
10
4
4
2
Non-Operating Interest Income
4
1
13
14
4
5
Minority Interest Expense
5
1
4
8
15
30

About Nantong Jinghua Pharmaceutical Co.

View Profile
Address
No. 9 Xingtai Road
Nantong Jiangsu 226005
China
Employees -
Website http://www.ntjhzy.com
Updated 07/08/2019
Nantong Jinghua Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals as well as involves in the research, development and sale of active pharmaceutical ingredients and intermediaries. Its products include Alendronate sodium, Alendronic acid, Benzobarbital, Azelaic acid, Moxonidine, Lornoxicam, Meloxicam, Piroxicam, and Strontium ranelate. The company was founded on January 3, 1994 and is headquartered in Nantong, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.